XENON PHARMACEUTICALS INC's ticker is XENE and the CUSIP is 98420N105. A total of 211 filers reported holding XENON PHARMACEUTICALS INC in Q4 2023. The put-call ratio across all filers is 0.84 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $13,926 | +110.0% | 357,178 | +131.9% | 0.10% | +86.3% |
| Q1 2024 | $6,631 | -12.9% | 154,038 | -6.8% | 0.05% | +2.0% |
| Q4 2023 | $7,612 | -38.1% | 165,267 | -54.1% | 0.05% | -57.3% |
| Q3 2023 | $12,292 | +13.4% | 359,838 | +18.8% | 0.12% | +30.0% |
| Q1 2023 | $10,844 | -98.9% | 302,980 | +867.0% | 0.09% | +650.0% |
| Q2 2022 | $953,000 | +426.5% | 31,332 | +164.0% | 0.01% | +500.0% |
| Q3 2021 | $181,000 | -27.3% | 11,866 | -40.3% | 0.00% | -66.7% |
| Q2 2020 | $249,000 | – | 19,888 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| BVF INC/IL | 3,516,851 | $44,101,000 | 2.72% |
| Parkman Healthcare Partners LLC | 590,267 | $7,402,000 | 2.08% |
| ACUTA CAPITAL PARTNERS, LLC | 517,500 | $6,489,000 | 1.88% |
| Soleus Capital Management, L.P. | 250,897 | $3,146,000 | 1.79% |
| DAFNA Capital Management LLC | 346,535 | $4,346,000 | 1.25% |
| KNOTT DAVID M | 169,000 | $2,119,000 | 1.16% |
| Ghost Tree Capital, LLC | 325,000 | $4,076,000 | 1.08% |
| Avoro Capital Advisors LLC | 2,800,000 | $35,112,000 | 0.69% |
| NEA Management Company, LLC | 992,107 | $12,441,000 | 0.50% |
| Orbimed Advisors | 2,497,917 | $31,324,000 | 0.44% |